These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 22183941)

  • 41. Infections related to healthcare in patients hospitalized in a Urology service: resistance patterns and adequacy of empirical antibiotic treatment as a prognostic factor.
    Benítez-Sala R; Medina-Polo J; Justo-Quintas J; Gil-Moradillo J; Pérez-Cadavid S; Arrébola-Pajares A; Sopeña-Sutil R; Lara-Isla A; Alonso-Isa M; González-Padilla DA; García-Rojo E; Miranda-Utrera N; Aguilar-Gisbert L; Tejido-Sánchez Á
    Actas Urol Esp (Engl Ed); 2019 Apr; 43(3):151-157. PubMed ID: 30470584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Sensitivity to antibiotics of bacteria from nosocomial infections. Evolution in resuscitation services of military hospitals].
    Garrabé E; Cavallo JD; Brisou P; Chapalain JC; Coué JC; Courrier P; Granic G; Hervé V; Koeck JL; Morillon M; Claude JD; Rouby Y; Teyssou R
    Presse Med; 2000 Sep; 29(27):1497-503. PubMed ID: 11045115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology meets econometrics: using time-series analysis to observe the impact of bed occupancy rates on the spread of multidrug-resistant bacteria.
    Kaier K; Meyer E; Dettenkofer M; Frank U
    J Hosp Infect; 2010 Oct; 76(2):108-13. PubMed ID: 20599296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial consumption, costs and resistance patterns: a two year prospective study in a Romanian intensive care unit.
    Axente C; Licker M; Moldovan R; Hogea E; Muntean D; Horhat F; Bedreag O; Sandesc D; Papurica M; Dugaesescu D; Voicu M; Baditoiu L
    BMC Infect Dis; 2017 May; 17(1):358. PubMed ID: 28532467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017.
    Jernigan JA; Hatfield KM; Wolford H; Nelson RE; Olubajo B; Reddy SC; McCarthy N; Paul P; McDonald LC; Kallen A; Fiore A; Craig M; Baggs J
    N Engl J Med; 2020 Apr; 382(14):1309-1319. PubMed ID: 32242356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increase of patients co-colonised or co-infected with methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium or extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Meyer E; Ziegler R; Mattner F; Schwab F; Gastmeier P; Martin M
    Infection; 2011 Dec; 39(6):501-6. PubMed ID: 21710119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Characteristics of bloodstream infections in adult patients of two third level centers of Córdoba, Argentina.].
    Saad EJ; Baenas DF; Boisseau CS; García MJ; Nuñez SA; Balderramo DC; Hernandez D; Caeiro JP
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Sep; 75(3):156-167. PubMed ID: 30296022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Extended-spectrum of beta-lactamases (ESBL): yesterday ESBL: and today ESBL, carbapenemase-producing and multiresistant bacteria].
    Ghebremedhin B
    Dtsch Med Wochenschr; 2012 Dec; 137(50):2657-62. PubMed ID: 23225190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and predictors of multidrug-resistant bacteremia in liver cirrhosis.
    Kim A; Song BG; Kang W; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Goh MJ
    Korean J Intern Med; 2024 May; 39(3):448-457. PubMed ID: 38715233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting.
    Nicoletti G; Schito G; Fadda G; Boros S; Nicolosi D; Marchese A; Spanu T; Pantosti A; Monaco M; Rezza G; Cassone A; Garaci E;
    J Chemother; 2006 Dec; 18(6):589-602. PubMed ID: 17267336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antimicrobial treatment of nosocomial intra-abdominal infections--new treatment options with tygecycline].
    Vyhnánek F; Adámková V; Duchác V; Teplan V; Jirásek T
    Rozhl Chir; 2009 Sep; 88(9):503-7. PubMed ID: 20052927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nosocomial and Community-Acquired Spontaneous Bacterial Peritonitis in patients with liver cirrhosis in China: Comparative Microbiology and Therapeutic Implications.
    Shi L; Wu D; Wei L; Liu S; Zhao P; Tu B; Xie Y; Liu Y; Wang X; Liu L; Zhang X; Xu Z; Wang F; Qin E
    Sci Rep; 2017 Apr; 7():46025. PubMed ID: 28382951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for drug-resistant pathogens in immunocompetent patients with pneumonia: Evaluation of PES pathogens.
    Ishida T; Ito A; Washio Y; Yamazaki A; Noyama M; Tokioka F; Arita M
    J Infect Chemother; 2017 Jan; 23(1):23-28. PubMed ID: 27729192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients.
    Jones RN
    Am J Med; 1996 Jun; 100(6A):3S-12S. PubMed ID: 8678095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites.
    Schultalbers M; Tergast TL; Simon N; Kabbani AR; Kimmann M; Zu Siederdissen CH; Gerbel S; Manns MP; Cornberg M; Maasoumy B
    United European Gastroenterol J; 2020 Jun; 8(5):567-576. PubMed ID: 32213043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intra-Abdominal Infections: Prevalence and Risk Factors of ESBLs Infections.
    Boontham P; Soontomrak R
    J Med Assoc Thai; 2015 Nov; 98(11):1097-103. PubMed ID: 26817180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
    Fernández J; Navasa M; Gómez J; Colmenero J; Vila J; Arroyo V; Rodés J
    Hepatology; 2002 Jan; 35(1):140-8. PubMed ID: 11786970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Study on prevalence and molecular mechanisms of antibacterial resistance in Gram-negative pathogens of nosocomial infections in hospitals of Moscow and Perm'].
    Mudrak DE; Ikriannikova LN; Sidorenko SV; Il'ina EN
    Antibiot Khimioter; 2007; 52(7-8):10-6. PubMed ID: 18986019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.